Case Comprehensive Cancer Center: Prostatic Neoplasms trials

The registry lists 46 Prostatic Neoplasms studies with Case Comprehensive Cancer Center as lead sponsor. 8 are open to participants now and 10 have results posted.

Phase 1 1Phase 2 11Phase 3 1No phase 34(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Investigation of Impact of AI on Prostate Cancer WorkflowRecruitingNCT07084779Not applicable
• Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AINot yet recruitingNCT07040501Not applicable
• Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)Not yet recruitingNCT06811454Not applicable
• Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate CancerRecruitingNCT06738303Phase 2
• MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)RecruitingNCT06150417Phase 2
• Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused UltrasoundRecruitingNCT05610852Not applicable
• Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate CancerRecruitingNCT05590624Not applicable
• Cleveland African American Prostate Cancer ProjectRecruitingNCT05469269Not applicable
• Apalutamide and Leuprolide in Intermediate and High-risk Prostate CancerCompletedNCT02770391Phase 2Results posted
• Pilot Study Evaluating the Role of Histopathology Correlation in Treatment PlanningCompletedNCT02681614Not applicableResults posted
• Improving Erectile Function and Quality of Life After Prostate Cancer TreatmentTerminatedNCT01996852Not applicableResults posted
• Enzalutamide in Patients With High-risk Prostate CancerCompletedNCT01927627Phase 2Results posted
• High-Dose Stereotactic Radiation for Prostate CancerCompletedNCT01664130Not applicableResults posted
• Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to ChemotherapyCompletedNCT01083368Phase 1/2Results posted
• GM-CSF in Treating Patients With Relapsed Prostate CancerCompletedNCT00908141Phase 2Results posted
• Stereotactic Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT00619515Not applicableResults posted
• Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00460031Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00276549Phase 2Results posted
• Robotic Telesurgery in UrologyWithdrawnNCT07541066Not applicable
• Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer SurvivorsCompletedNCT06435871Not applicable
• NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsCompletedNCT05978232Not applicable
• Patient Recall of Cancer Screening and DiagnosisWithdrawnNCT05014295Not applicable
• Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseWithdrawnNCT04765423Not applicable
• Single-Port Versus Multi-Port Robotic Radical ProstatectomyWithdrawnNCT04696263Not applicable
• Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate CancerCompletedNCT04556045Not applicable
• Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate CancerWithdrawnNCT03823001Not applicable
• Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate CancerWithdrawnNCT03817216Not applicable
• Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer ScreeningCompletedNCT03387527Not applicable
• Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate CancerCompletedNCT03290417Not applicable
• Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate CancerWithdrawnNCT03157947Not applicable
• PSA TOOL for Prostate Cancer Screening DiscussionsCompletedNCT03135444Not applicable
• Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate CancerWithdrawnNCT03122470Not applicable
• A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive TumorsCompletedNCT02978586
• Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach ProgramTerminatedNCT02419846Not applicable
• Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate CancerWithdrawnNCT02179762Not applicable
• Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate CancerCompletedNCT02163317Not applicable
• MRI Before Biopsy in Diagnosing Patients With Prostate CancerTerminatedNCT02131207
• Robotic Athermal Nerve-Sparing Radical ProstatectomyWithdrawnNCT02079155Not applicable
• Treatment Decision Analysis Model for Prostate Cancer: A Randomized TrialTerminatedNCT02024685Not applicable
• Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate CancerWithdrawnNCT01750866Phase 2
• Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryTerminatedNCT01340599Phase 2
• Psychosocial Adjustment After Radiation Therapy in Patients With CancerCompletedNCT00905086
• Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsCompletedNCT00898274
• Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.CompletedNCT00258401Not applicable
• Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate CancerCompletedNCT00244309Phase 3
• Liposomal Doxorubicin in Treating Patients With Prostate CancerCompletedNCT00004014Phase 2